Dare Bioscience, Inc. (DARE) stock forecast and price target
Price $0.66 · data as of November 13, 2026
12-month price target
Average target$6.33
Upside / downside+863.4%
Analysts3
ConsensusNone
Low $2.00Average $6.33High $12.00
Gold marker: average target · white marker: today’s price ($0.66)
Analyst ratings
Strong buy 0Buy 3Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.73 | +39.4% | $3M |
| Next fiscal year ends December 31, 2027 | $-0.51 | +29.8% | $7M |
| Quarter after ends December 31, 2026 | $-0.20 | −98.8% | $376000 |
Consensus of the analysts covering Dare Bioscience, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Dare Bioscience stock price target?
The average 12-month target from 3 analysts is $6.33, 863.4% above the current price of $0.66 Targets range from $2.00 to $12.00.
Is Dare Bioscience a buy according to analysts?
The consensus rating is “None” (3 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Dare Bioscience expected to earn?
Analysts expect EPS of $-0.73 for the fiscal year ending December 31, 2026 and $-0.51 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.